Carney complex: Clinical and genetic 2010 update

Ann Endocrinol (Paris). 2010 Dec;71(6):486-93. doi: 10.1016/j.ando.2010.08.002. Epub 2010 Sep 17.

Abstract

First described in the mid 1980s, Carney complex is a rare dominantly heritable multiple endocrine neoplasia syndrome that affects endocrine glands as the adrenal cortex, the pituitary and the thyroid. It is associated with many other nonendocrine tumors, including cardiac myxomas, testicular tumors, melanotic schwannoma, breast myxomatosis, and abnormal pigmentation or myxomas of the skin. The Carney complex gene 1 was identified 10 years ago as the regulatory subunit 1A of protein kinase A (PRKAR1A) located at 17q22-24. An inactivating heterozygous germ line mutation of PRKAR1A is observed in about two-thirds of Carney complex patients. This last decade many progresses have been done in the knowledge of this rare disease and its genetics. This review outlines the current state of this knowledge on Carney complex.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Diseases / etiology
  • Bone Diseases / pathology
  • Breast Diseases / etiology
  • Breast Diseases / pathology
  • Carney Complex / complications
  • Carney Complex / genetics*
  • Carney Complex / pathology*
  • Cyclic AMP-Dependent Protein Kinase RIalpha Subunit / genetics
  • Endocrine Glands / pathology
  • Gonads / pathology
  • Heart Diseases / etiology
  • Heart Diseases / pathology
  • Humans
  • Myxoma / etiology
  • Myxoma / pathology
  • Phosphoric Diester Hydrolases / genetics
  • Skin Diseases / etiology
  • Skin Diseases / pathology

Substances

  • Cyclic AMP-Dependent Protein Kinase RIalpha Subunit
  • PRKAR1A protein, human
  • Phosphoric Diester Hydrolases